The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
about
Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care unitsOverutilization of proton-pump inhibitors: what the clinician needs to knowPrevention of stress-related ulcer bleeding at the intensive care unit: Risks and benefits of stress ulcer prophylaxisRisks and benefits of stress ulcer prophylaxis in adult neurocritical care patients: a systematic review and meta-analysis of randomized controlled trialsA review of stress-related mucosal diseaseStress ulcer prophylaxis in the intensive care unit: is it indicated? A topical systematic reviewStress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients. A systematic review of randomised clinical trials with meta-analysis and trial sequential analysisStress ulcer prophylaxis versus placebo or no prophylaxis in adult hospitalised acutely ill patients-protocol for a systematic review with meta-analysis and trial sequential analysis.Risk score to predict gastrointestinal bleeding after acute ischemic strokeEffects of ranitidine and pantoprazole on ventilator-associated pneumonia: a randomized double-blind clinical trial.Evaluation of costs accrued through inadvertent continuation of hospital-initiated proton pump inhibitor therapy for stress ulcer prophylaxis beyond hospital discharge: a retrospective chart reviewUlcer healing and mechanism(s) of action involved in the gastroprotective activity of fractions obtained from Syngonanthus arthrotrichus and Syngonanthus bisulcatus.Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials.Indication of acid suppression therapy and predictors for the prophylactic use of protonpump inhibitors vs. histamine-2 receptor antagonists in a Malaysian tertiary hospital.Intensive care unit capacity strain and adherence to prophylaxis guidelines.Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.Management by the intensivist of gastrointestinal bleeding in adults and children.Reduction in gastrointestinal bleeding by development and implementation of a protocol for stress ulcer prophylaxis: a before-after study.Use of acid suppressive therapy in hospitalized non-critically ill patients.Defining Appropriate Use of Proton-Pump Inhibitors Among Medical Inpatients.Xiaotan Tongfu granules contribute to the prevention of stress ulcers.Gastroprotective effects of arctigenin of Arctium lappa L. on a rat model of gastric ulcers.Severe sepsis and septic shock: management and performance improvement.Gastrointestinal prophylaxis in neurocritical care.Safety of enteral feeding in patients with open abdomen, upper gastrointestinal bleed, and perforation peritonitis.Patterns of use of prophylaxis for stress-related mucosal disease in patients admitted to the intensive care unit.Use of proton pump inhibitors for the provision of stress ulcer prophylaxis: clinical and economic consequences.Proton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse events.Stress-related mucosal disease in the critically ill patient.Clinical Outcomes of Acid Suppressive Therapy Use in Hematology/Oncology Patients at an Academic Medical Center.Risk of Clostridium difficile Infection with the Use of a Proton Pump Inhibitor for Stress Ulcer Prophylaxis in Critically Ill Patients.A survey of prescriber perceptions about the prevention of stress-related mucosal bleeding in the intensive care unit.Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppressionAn interprofessional approach to reducing the overutilization of stress ulcer prophylaxis in adult medical and surgical intensive care units.Gastroprotective effects (in rodents) of a flavonoid rich fraction obtained from Syngonanthus macrolepsis.[Stress lesions in the upper gastrointestinal tract].Stress Ulcer Prophylaxis in Neurocritical Care.
P2860
Q24235774-4084D28B-4267-476B-A794-DA67B365F2FCQ24634086-FF459A80-451C-4656-AA0C-D836EA5E67D7Q26768234-65CB5E96-29F4-4F08-A924-30B06F17F682Q28082798-9EAD60B4-E23B-4158-976C-4969DB9A6AA5Q28259245-29EFF1D9-0B98-428A-8544-79FA29939701Q28287257-524ECDEE-8CB3-4081-8566-8EE48A7DD6E1Q28300556-263AFF30-8241-4C4C-A4C1-0EFD5C7F1361Q33831121-047E04C6-4D80-408C-AFBE-695D766D22E7Q33997632-492DF813-2695-4680-BA52-8AC2F9ED53EBQ34126810-49B594D9-385D-486C-8282-F5A34C738C94Q35571775-913AC46A-0170-4915-9392-A89CB68F3862Q35825245-B52BC77C-9E67-48C9-8B22-D625536E4794Q36007773-7E34260A-C9F7-4446-8921-EAAD0A7A599AQ36092263-632ADBC5-BF43-4F4D-AE23-ACF1FD036BE7Q36236868-F85F8D5A-0AB3-4AC4-A748-5EA3B906D68EQ36281234-264D4929-4DD2-4925-AF60-EC80643CF4A5Q36478606-D77D5FD0-434C-4658-81C4-7562DF9FEFA8Q36508618-B38882D1-C674-4824-87F4-DFA6EFE1C393Q36681352-5B154335-3350-4B09-87F0-CCD67FA4097EQ36717591-3460EDCF-43A2-43AA-9620-E74CBED50DDBQ37142211-E4BF27AB-6AF7-4153-B2C3-DA49BC502AB8Q37406285-C272F993-0ED5-48DE-B721-9660677E6BDBQ37562996-63ED3F68-773C-44A3-AEC1-DB92AE673BADQ37900222-14EA19DA-0120-4E5B-9DA9-9E4581FC7BE1Q38018502-3BB5187A-F64B-4647-8F78-442B5BCF8251Q38025609-3E53FB16-F31D-4796-B045-58E6446920B2Q38165810-3F5991E7-5A54-4B77-9D73-97B377EE56A0Q38271282-938F5C5A-DF46-4A7C-8E03-E4F420605DF2Q38308249-0C22A0A5-1B4D-43E7-B418-2C8EDFACE435Q38811584-254C0D7D-E4D3-44DA-ADFC-AAEA8C11BDA8Q39883684-08AA4A43-F9CA-4561-A329-3242F271A502Q41730777-2B361F64-9423-461A-857F-9AEC620F0788Q42371575-241E66D6-771A-403D-86D0-E0D3E20EE887Q43800964-4F38FA82-979A-478F-9AF3-53D9A0A45EA8Q44004380-ED2BB836-829F-4C49-B969-1BF344D5EAF7Q44588685-F73BAA25-5AF1-4CE4-841E-9E4B782E06F0Q47956386-AC6EABDA-8A3D-4168-9F61-84637FA295AB
P2860
The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The efficacy and safety of pro ...... are patients: a meta-analysis.
@ast
The efficacy and safety of pro ...... are patients: a meta-analysis.
@en
The efficacy and safety of pro ...... are patients: a meta-analysis.
@nl
type
label
The efficacy and safety of pro ...... are patients: a meta-analysis.
@ast
The efficacy and safety of pro ...... are patients: a meta-analysis.
@en
The efficacy and safety of pro ...... are patients: a meta-analysis.
@nl
prefLabel
The efficacy and safety of pro ...... are patients: a meta-analysis.
@ast
The efficacy and safety of pro ...... are patients: a meta-analysis.
@en
The efficacy and safety of pro ...... are patients: a meta-analysis.
@nl
P2093
P1476
The efficacy and safety of pro ...... are patients: a meta-analysis.
@en
P2093
Pei-Chin Lin
Pi-Lai Tseng
Ping-I Hsu
Yaw-Bin Huang
P304
P356
10.1097/CCM.0B013E3181D69CCF
P407
P577
2010-04-01T00:00:00Z